Condyloma
0
Pipeline Programs
4
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
VaxartAP611074 5% gel
CEL-SCILeukocyte Interleukin, Injection 200IU
MSDEffectiveness Study of Gardasil on Condyloma
Clinical Trials (3)
Total enrollment: 500,222 patients across 3 trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients
Start: Jan 2016Est. completion: Jul 2018218 patients
Phase 2Completed
Safety Study of Multikine in the Treatment of Perianal Warts
Start: Apr 2014Est. completion: Jan 20164 patients
Phase 1Terminated
Effectiveness Study of Gardasil on Condyloma
Start: Jun 2006Est. completion: Dec 2010500,000 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.